NCR3 and neoplasm: ,18,19,20 Thus, we hypothesized that engineering NKp30-based NKCEs that do not compete with B7-H6 for binding to NKp30 would enable natural tumor recognition via B7-H6, thereby maximizing the effects of the NKCEs.